[go: up one dir, main page]

UY29237A1 - Metodos detratamiento y prevencion - Google Patents

Metodos detratamiento y prevencion

Info

Publication number
UY29237A1
UY29237A1 UY29237A UY29237A UY29237A1 UY 29237 A1 UY29237 A1 UY 29237A1 UY 29237 A UY29237 A UY 29237A UY 29237 A UY29237 A UY 29237A UY 29237 A1 UY29237 A1 UY 29237A1
Authority
UY
Uruguay
Prior art keywords
prevention
treatment
methods
xylopyranoside
benzopyran
Prior art date
Application number
UY29237A
Other languages
English (en)
Spanish (es)
Inventor
Jeffrey W Dubb
Linda S Henderson
Shunichiro S Okada
Vincent Peyrou
Robert E Samuels
Sunita Sheth
Patricia A Spera
John R Toomey
Douglas E Wilson
Original Assignee
Glaxo Group Ltd
Fournier Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36565378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29237(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd, Fournier Lab Sa filed Critical Glaxo Group Ltd
Publication of UY29237A1 publication Critical patent/UY29237A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UY29237A 2004-12-01 2005-11-29 Metodos detratamiento y prevencion UY29237A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63215304P 2004-12-01 2004-12-01
US69172805P 2005-06-17 2005-06-17
US72169105P 2005-09-29 2005-09-29
US72471005P 2005-10-07 2005-10-07

Publications (1)

Publication Number Publication Date
UY29237A1 true UY29237A1 (es) 2006-05-31

Family

ID=36565378

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29237A UY29237A1 (es) 2004-12-01 2005-11-29 Metodos detratamiento y prevencion

Country Status (5)

Country Link
AR (1) AR053789A1 (fr)
PE (1) PE20061246A1 (fr)
TW (1) TW200635580A (fr)
UY (1) UY29237A1 (fr)
WO (1) WO2006060647A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801055B1 (fr) * 1999-11-17 2002-02-08 Fournier Ind & Sante Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
AR053789A1 (es) 2007-05-23
TW200635580A (en) 2006-10-16
WO2006060647A1 (fr) 2006-06-08
PE20061246A1 (es) 2006-11-08

Similar Documents

Publication Publication Date Title
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
ECSP10010007A (es) Tratamiento con ligandos alpha-7-selectivos
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MY147247A (en) Organic compounds and their uses
PT2275097T (pt) Composições que incluem canabinoides para tratamento de náuseas, vómitos, émese, enjoo ou condições idênticas
ECSP077421A (es) Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
MX2021015992A (es) Azacitidina en combinación con venetoclax, gilteritinib, midostaurina u otros compuestos para tratamiento de leucemia o síndrome mielodisplásico.
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
CL2007003520A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
WO2009009417A3 (fr) Compositions pharmaceutiques et procédés pour prévenir, traiter ou inhiber des maladies, des troubles ou des affections inflammatoires cutanés et des maladies, des troubles ou des affections associés à un appauvrissement en collagène
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
WO2009009034A3 (fr) Procédées et compositions utiles dans le traitement de la mucosite
CY1111762T1 (el) Διενυδρη παμοϊκη ολανζαπiνη
PA8597501A1 (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
BRPI0808823A2 (pt) composição e método para tratar, reduzir, melhorar ou prevenir uma infecção.